Literature DB >> 33498571

A Vicious Cycle of Osteosarcopeniain Inflammatory Bowel Diseases-Aetiology, Clinical Implications and Therapeutic Perspectives.

Dorota Skrzypczak1, Alicja Ewa Ratajczak1, Aleksandra Szymczak-Tomczak1, Agnieszka Dobrowolska1, Piotr Eder1, Iwona Krela-Kaźmierczak1.   

Abstract

Sarcopenia is a disorder characterized by a loss of muscle mass which leads to the reduction of muscle strength and a decrease in the quality and quantity of muscle. It was previously thought that sarcopenia was specific to ageing. However, sarcopenia may affect patients suffering from chronic diseases throughout their entire lives. A decreased mass of muscle and bone is common among patients with inflammatory bowel disease (IBD). Since sarcopenia and osteoporosis are closely linked, they should be diagnosed as mutual consequences of IBD. Additionally, multidirectional treatment of sarcopenia and osteoporosis including nutrition, physical activity, and pharmacotherapy should include both disorders, referred to as osteosarcopenia.

Entities:  

Keywords:  Crohn’s disease; IBD; low muscle mass; low muscle strength; malnutrition; nutritional therapy; sarcopenia; ulcerative colitis

Mesh:

Substances:

Year:  2021        PMID: 33498571      PMCID: PMC7909530          DOI: 10.3390/nu13020293

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  167 in total

Review 1.  Bone's mechanostat: a 2003 update.

Authors:  Harold M Frost
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2003-12

2.  Habitual physical activity, anabolic hormones, and potassium content of fat-free mass in postmenopausal women.

Authors:  Ross D Hansen; Barry J Allen
Journal:  Am J Clin Nutr       Date:  2002-02       Impact factor: 7.045

3.  Nutritional status and food intake in pediatric patients with inflammatory bowel disease at diagnosis significantly differs from healthy controls.

Authors:  Sara Sila; Ivana Trivić; Ana Močić Pavić; Tena Niseteo; Sanja Kolaček; Iva Hojsak
Journal:  Eur J Pediatr       Date:  2019-08-17       Impact factor: 3.183

4.  Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines.

Authors:  Bente K Pedersen
Journal:  J Appl Physiol (1985)       Date:  2009-08-20

5.  The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease.

Authors:  Michael Pazianas; Andrew D Rhim; Andrew M Weinberg; Chinyu Su; Gary R Lichtenstein
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

6.  International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; H Arai; S B Kritchevsky; J Guralnik; J M Bauer; M Pahor; B C Clark; M Cesari; J Ruiz; C C Sieber; M Aubertin-Leheudre; D L Waters; R Visvanathan; F Landi; D T Villareal; R Fielding; C W Won; O Theou; F C Martin; B Dong; J Woo; L Flicker; L Ferrucci; R A Merchant; L Cao; T Cederholm; S M L Ribeiro; L Rodríguez-Mañas; S D Anker; J Lundy; L M Gutiérrez Robledo; I Bautmans; I Aprahamian; J M G A Schols; M Izquierdo; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

7.  Persistence of Muscle-bone Deficits Following Anti-tumour Necrosis Factor Therapy in Adolescents With Crohn Disease.

Authors:  Mabrouka M A Altowati; Sheila Shepherd; Martin McMillan; Paraic McGrogan; Richard Russell; S Faisal Ahmed; Sze Choong Wong
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-12       Impact factor: 2.839

8.  Omega-3 supplementation with resistance training does not improve body composition or lower biomarkers of inflammation more so than resistance training alone in older men.

Authors:  Stephen M Cornish; Semone B Myrie; Eric M Bugera; Jeremie E Chase; David Turczyn; Mark Pinder
Journal:  Nutr Res       Date:  2018-09-19       Impact factor: 3.315

Review 9.  A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach.

Authors:  Helen C Roberts; Hayley J Denison; Helen J Martin; Harnish P Patel; Holly Syddall; Cyrus Cooper; Avan Aihie Sayer
Journal:  Age Ageing       Date:  2011-05-30       Impact factor: 10.668

10.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

View more
  1 in total

Review 1.  Inflammatory Bowel Diseases: Is There a Role for Nutritional Suggestions?

Authors:  Lorenzo Bertani; Davide Giuseppe Ribaldone; Massimo Bellini; Maria Gloria Mumolo; Francesco Costa
Journal:  Nutrients       Date:  2021-04-20       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.